Industry
Drug Manufacturers - Specialty & Generic
Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.
Loading...
Open
7.11
Mkt cap
396M
Volume
201K
High
7.92
P/E Ratio
-10.32
52-wk high
8.36
Low
7.11
Div yield
N/A
52-wk low
1.16
Portfolio Pulse from Benzinga Newsdesk
May 14, 2024 | 1:42 pm
Portfolio Pulse from Benzinga Newsdesk
May 13, 2024 | 8:41 pm
Portfolio Pulse from Benzinga Newsdesk
May 13, 2024 | 8:16 pm
Portfolio Pulse from Benzinga Insights
March 26, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Newsdesk
March 12, 2024 | 11:35 am
Portfolio Pulse from Benzinga Insights
March 11, 2024 | 8:10 pm
Portfolio Pulse from Benzinga Newsdesk
March 11, 2024 | 8:09 pm
Portfolio Pulse from Benzinga Insights
March 11, 2024 | 8:56 am
Portfolio Pulse from Benzinga Insights
March 08, 2024 | 3:01 pm
Portfolio Pulse from Benzinga Newsdesk
November 09, 2023 | 10:53 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.